Product correctly added to cart.

discount label
ZINC77292789
View 3D

Targetmol logo

ZINC77292789

CAS: 116783-35-8

Ref. TM-TP1166

1mg
51.00 €
2mg
73.00 €
5mg
106.00 €
10mg
158.00 €
25mg
254.00 €
50mg
441.00 €
100mg
631.00 €
Estimated delivery in United States, on Friday 12 Apr 2024

Product Information

Name:
ZINC77292789
Synonyms:
  • Fmoc-Thr[GalNAc(Ac)3-α-D]-OH, Fmoc-Thr(Ac₃AcNH-α-Gal)-OH
Description:

ZINC77292789 (Fmoc-Thr[GalNAc(Ac)3-α-D]-OH) is a reagent for the preparation of a synthetic MUC1 Glycopeptide Bearing βGalNAc-Thr as a Tn antigen isomer which induces the antibody production against tumor cells. ZINC77292789 is a starting material to make trimeric MUC1 immunodominant motif antigen-based anti-cancer vaccine candidates.

Brand:
Targetmol
Long term storage:
Notes:

Chemical properties

Molecular weight:
670.66
Formula:
C33H38N2O13
Purity:
99.24%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: TM-TP1166 ZINC77292789

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!Please accept the use of cookies to have a better experience on our website.

Cookies are important for you, they influence your browsing experience, they help us to protect your privacy and allow us to proceed with the requests that you demand through this website. We use our own and third-party cookies to analyze our services. If you consent to its installation, click on "Accept", otherwise click on "Reject". You can also set your preferences by clicking "Settings". More information is available in our Cookies Policy.